Introduction
============

The core mechanism underlying the circadian clock is coupled transcriptional/translational feedback loops that interact in a temporal manner to establish the proper period and phasing of clock gene expression ([@B1]--[@B4]). Predominant control comes from a negative feedback loop, although examples of rhythms occurring independent of transcription are known to occur ([@B5], [@B6]). The core feedback loop consists of a heterodimeric transcriptional activator complex that drives expression of inhibitors ([@B7]--[@B9]). This heterodimeric complex is composed of White Collar 1 (WC-1) and WC-2 in *Neurospora* ([@B10]), CLOCK, and CYCLE in *Drosophila* ([@B11]--[@B13]) and CLOCK and BMAL1 in mammals ([@B14]--[@B17]). These activate transcription of clock and clock-associated genes. Transcription and subsequent translation of negative elements eventually block further expression by inhibiting the positive elements. The negative elements are *frequency* (*frq*) and FRQ-interacting RNA helicase (*frh*) in *Neurospora* ([@B18], [@B19]), *Period* (*Per*) and *Timeless* (*Tim*) in *Drosophila* ([@B20], [@B21]), and *Per* and *cryptochrome* (*Cry*) in mammals ([@B22]--[@B25]). Both the positive and negative elements are post-translationally modified by a subset of kinases and phosphatases in tightly coupled reactions. These timed modifications ultimately lead to inactivation and turnover of the core clock proteins via the ubiquitin-proteasome pathway ([@B26]--[@B37]). Evidence suggests FRQ undergoes a conformational change induced by the kinase activity of casein kinase Ia that creates an accessible PEST1 domain needed for turnover ([@B38]). The molecular events occur such that circadian transcription oscillates in an ∼24-h period. Recent advances in our studies of the clock indicate that it controls chromatin structure, and proper chromatin structure is a requisite for normal clock gene oscillations, indicating higher order regulation in the activation and feedback mechanisms ([@B39]--[@B43]).

Eukaryotic chromatin packages DNA, and histone modifications help maintain the genome in a condensed or accessible state. The histones that compose the nucleosome have unstructured protruding amino-terminal tails that are modified individually or in tandem, and they serve as signaling platforms that can elicit a context-dependent outcome on gene expression ([@B44], [@B45]). Chromatin modifications and remodeling occur over the circadian cycle, and evidence indicates oscillations in facultative heterochromatic states ([@B46]). There are cycles in modifications considered permissive in the activation phases and repressive in the feedback inhibition phase. For example, rhythmic histone lysine acetylation has been observed in histone H3 in *mPer1*, *mPer2*, and *Cry1* promoters with the peaks occurring during the transcriptionally active phase ([@B47], [@B48]). Affinity-purified CLOCK protein associates with the ubiquitous KAT3B, p300 ([@B47]), and has catalytic acetyltransferase activity ([@B49]), indicating the clock can direct chromatin modifications. Rhythms in acetylation have led to the identification of a growing list of histone deacetylases that include HDAC1 and HDAC2 (part of the Sin3B complex) ([@B50]) and the NAD-dependent histone deacetylase SIRT1 ([@B51], [@B52]). Moreover, deacetylation by the Sin3A complex and subsequent repressive modifications may be recruited by paraspeckle proteins NONO and PSF ([@B41], [@B53]).

Methylation and demethylation are also involved in circadian-regulated gene expression. During the repressive phase, there is di- and trimethylation of H3K27 at *mPer1* and *mPer2,* which is dependent on the polycomb group protein EZH2 (KMT6) ([@B54]). Oscillating changes in H3K9 from acetylated to methylated states are observed at the albumin D-element binding protein (*Dbp*) gene, and HP1 is bound to H3K9me2 during the repressive phase ([@B46]). Methyl modifications considered activating also have a role in the clock. The mammalian KMT2, MLL1, associates with CLOCK-BMAL1 and directs H3K4 methylation at clock loci ([@B46], [@B55]). KMD5A (JARID1A) also associates with CLOCK-BMAL1 and is implicated in clock gene expression, but presumably, it does not demethylate H3K4 at clock loci. Instead it inhibits histone deacetylation ([@B42]). Additionally, the H3K36 lysine demethylase Jmj5B (KDM8) is rhythmically expressed in *Arabidopsis* and mammals, and it is needed to maintain WT period lengths ([@B43]).

Modifications to histones and DNA are recognized by cofactors and ATP-dependent chromatin-remodeling enzymes to elicit the proper transcriptional response. In *Neurospora*, two ATP-dependent chromatin-remodeling enzymes, Clockswitch (CSW-1/CRF10) (*Saccharomyces cerevisiae* Fun30, *Schizosaccharomyces pombe* Ftf3, *Mus* ETL1, and *Homo sapiens* SMARCAD1), and chromo-domain helicase DNA-binding protein 1 (CHD1), are needed for proper circadian regulation of *frq*. CSW-1 remodels chromatin at the *frq* c-box element to inhibit the association of WC-2 with the promoter, generating circadian-regulated accessible chromatin ([@B40]). CHD1 remodels chromatin at the *frq* antisense promoter and is needed to maintain the proper amplitude of clock gene expression ([@B39]). The CHD7 homologue Kismet in *Drosophila* is required for normal photoresponses and assists Cry-dependent transcriptional responses ([@B57]).

The combination of changing chromatin modifications and ATP-dependent remodeling at clock-associated loci suggests a complex mechanism of chromatin structural changes under the control of the clock that is needed for activation and feedback. Understanding how all this contributes to coordinate circadian-regulated gene expression, with respect to the timing and amplitude, is paramount to our basic knowledge of the biological clock and cellular homeostasis. In this study, we show that SET1 plays a role in circadian- and light-regulated gene expression. Specifically, H3K4 methylation appears to attenuate the expression of *frq* under circadian conditions. Moreover, loss of *set1* results in elevated expression of a subset of light-activated genes. Under both circadian- and light-activated expression, the peak in H3K4 methylation at *frq* appears to lag the peak in gene expression, supporting the notion that in the absence of SET1 the chromatin at *frq* is more accessible.

EXPERIMENTAL PROCEDURES
=======================

### 

#### Strains and Growth Conditions

All the strains utilized in this study are listed in [Table 1](#T1){ref-type="table"}. *Neurospora* conidia were suspended in 2% liquid culture medium (LCM) (1× Vogel\'s salts, 2% glucose, 0.17% arginine) and grown in 75-mm Petri dishes overnight at 30 °C to generate mycelia mats. Plugs were cut and used to inoculate flasks containing 50 ml of 2% LCM and grown at 25 °C for 2 days. For circadian time course experiments, strains were entrained with a standard light to dark transfer and harvested after a timed incubation in the dark (4, 8, 12, 16, 20, 24, 28, 32, 36, 40, and 44 h). Growth to examine the light response was done in a similar fashion except cultures were incubated in the light for 24 h, transferred to dark for 24 h, and then treated with saturating light for 15, 30, 60, 120, and 240 min. Tissue was harvested by filtration, frozen in liquid nitrogen, and then ground with a mortar and pestle in the presence of liquid nitrogen. Race tube medium consisted of 1× Vogel\'s salts, 0.1% glucose, 0.17% arginine, 50 mg/ml biotin, and 1.5% agar. Tubes were grown for 12--24 h in the light and transferred to the dark marking the growth front at 24-h intervals. All strains grown on race tubes contained the *ras-1^bd^* allele that facilitates observation of the rhythm in conidia formation ([@B58]), and all molecular analyses were done on deletion strains that were otherwise isogenic to FGSC2489. Luciferase experiments were performed as described using pVG110 ([@B59]), and data were acquired with μManager software and quantified with ImageJ ([@B60]).

###### 

**Strains**

  Strain      Genotype                         Source[*^a^*](#TF1-1){ref-type="table-fn"}
  ----------- -------------------------------- --------------------------------------------
  FGSC2489    OR74, A (WT)                     FGSC
  FGSC4200    OR74, a (WT)                     FGSC
  FGSC15827   *ncu01206* (*set-1*)::*hph, A*   FGSC
  FGSC15828   *ncu01206* (*set-1*)::*hph, a*   FGSC
  FGSC16051   *ncu02104* (*swd1*)::*hph, A*    FGSC
  FGSC13701   *ncu07885* (*swd2*)::*hph, a*    FGSC
  FGSC11360   *ncu03244* (*swd3*)::*hph, a*    FGSC
  FGSC14862   *ncu03037* (*sdc1*)::*hph, a*    FGSC
  FGSC11914   *ncu06266* (*dot1*)::*hph, a*    FGSC
  XB140-10    *set1*::*hph, A*                 This study
  94--40      *frq*^9^, *ras-1^bd^*, *A*       [@B83]
  XB77-1      *set1*::*hph, ras-1^bd^*         This study
  XB78-3      *swd1*::*hph, ras-1^bd^*         This study
  XB79-5      *swd2*::*hph, ras-1^bd^*         This study
  XB80-3      *swd3*::*hph, ras-1^bd^*, *a*    This study
  XB81-3      *sdc1*::*hph, ras-1^bd^*, *a*    This study
  XB98-3      *dim-2*::*hph, ras-1^bd^*, *a*   [@B39]
  XB136-6     *ras-1^bd^*, *A*                 This study
  XB136-5     *ras-1^bd^*, *A*                 This study
  9014-VG3    *pVG110*::*his3, A*              [@B59]
  XB 157-25   *pVG110*::*his3, set1*::*hph*    This study
  XB 157-30   *pVG110*::*his3, set1*::*hph*    This study
  XB 157-31   *pVG110*::*his3, set1*::*hph*    This study

*^a^* FGSC: Fungal Genetics Stock Center.

#### RNA Extraction and Quantitative PCR

Total RNA was extracted using TRIzol (Invitrogen) following the manufacturer\'s guidelines. Briefly, 1 ml of TRIzol was added to an ∼100 μl volume of ground tissue from each sample and then vortexed vigorously. The mixture was subjected to centrifugation at 13,000 × *g* for 10 min to pellet cell debris. The organic TRIzol (800 μl) was transferred to a new tube, and the aqueous phase containing RNA was separated by the addition of 200 μl of chloroform followed by centrifugation at 13,000 × *g* for 10 min. The supernatant (250 μl) was transferred to a new tube, and the RNA was precipitated by the addition of isopropyl alcohol (250 μl) and centrifuged at 13,000 × *g* for 10 min. The RNA pellet was washed with 70% EtOH, then dried, and suspended in 50 μl of RNase-free 10 m[m]{.smallcaps} Tris-HCl, pH 7.5. Prior to the reverse transcription, DNA was removed by treatment with DNase I (Ambion TURBO DNA-*free*) following the manufacturer\'s guidelines. cDNA libraries were generated using a random hexamer and the High Capacity Reverse Transcriptase (Invitrogen). Quantitative PCR was performed using SYBR Green PCR Mastermix (Invitrogen) with oligonucleotides specific for *frq, wc-1, vvd, dim-2,* and *al-2* all normalized relative to *rac-1*.

#### Immunoblot Analysis

Proteins were extracted from ground lysate in protein extraction buffer (PEB) (50 m[m]{.smallcaps} Hepes, pH 7.4, 137 m[m]{.smallcaps} KCl, 10% glycerol, and 1 m[m]{.smallcaps} EDTA) plus protease inhibitors (PI) (1 m[m]{.smallcaps} PMSF, 1 μg/ml leupeptin, 1 μg/ml pepstatin, and 1 m[m]{.smallcaps} DTT). 250 μl of ice-cold PEB + PI was mixed with a 100-μl volume of ground tissue and vortexed five times for 1 min with incubations on ice between vortexing and maintaining the lysates at ∼4 °C. Soluble protein was isolated by centrifugation at 13,000 × *g* for 10 min at 4 °C. The protein samples were normalized and diluted with 5× sample buffer (0.125 [m]{.smallcaps} Tris-HCl, pH 6.8, 25% glycerol, 4% SDS, 5% 2-mercaptoethanol, with bromphenol blue), to a final concentration of 2×. The protein was then heat-denatured, separated on 6.5% SDS-polyacrylamide gels, and then transferred to a PVDF membrane. Proteins were detected with primary polyclonal antibody specific for FRQ ([@B31]) and WC-1 ([@B61]). The blots were washed with PBST (phosphate-buffered saline with 0.3% Tween 20), incubated with secondary antibody, treated with chemiluminescent substrate, and then exposed to film.

#### Isolation of Nuclei

Nuclei were extracted from *Neurospora* tissue following an established protocol with modifications ([@B62]). 30 μl of conidia suspension was used to seed a 250-ml culture containing 2% LCM and grown under a standard time course procedure. Tissue was harvested and ground in the presence of 0.2 g of acid-washed glass beads (Sigma) and incubated in 4 ml of buffer A (1 [m]{.smallcaps} sorbitol, 7% Ficoll-PM70, 20% glycerol, 5 m[m]{.smallcaps} magnesium acetate, 3 m[m]{.smallcaps} calcium chloride, 50 m[m]{.smallcaps} Tris-HCl, pH 7.5, 3 m[m]{.smallcaps} DTT, 1 m[m]{.smallcaps} PMSF, 0.01 mg/ml pepstatin A, 0.01 mg/ml leupeptin) on ice. The lysate was filtered through cheesecloth, and 8 ml of buffer B (10% glycerol, 5 m[m]{.smallcaps} magnesium acetate, 25 m[m]{.smallcaps} Tris-HCl, pH 7.5, 1 m[m]{.smallcaps} PMSF, 1 μg/ml pepstatin A, 1 μg/ml leupeptin) was added dropwise to the filtered liquid with gentle stirring. The solution was spun at 3,000 × *g* for 7 min at 4 °C in an SW40 rotor (Beckman), and the supernatant was subjected to 6--10 strokes of homogenization using Wheaton Potter-Elvehjem Tissue Grinders (Fisher). Approximately 10 ml of homogenized supernatant was layered on a 2-ml step gradient consisting of 1 ml of buffer D (1 [m]{.smallcaps} sucrose, 10% glycerol, 5 m[m]{.smallcaps} magnesium acetate, 25 m[m]{.smallcaps} Tris-HCl, pH 7.5, 1 m[m]{.smallcaps} DTT, 1 m[m]{.smallcaps} PMSF, 0.01 mg/ml pepstatin A, 0.01 mg/ml leupeptin) layered on 1 ml of buffer D+ (1.2 [m]{.smallcaps} sucrose, 10% glycerol, 5 m[m]{.smallcaps} magnesium acetate, 25 m[m]{.smallcaps} Tris-HCl, pH 7.5, 1 m[m]{.smallcaps} DTT, 1 m[m]{.smallcaps} PMSF, 0.01 mg/ml pepstatin A, 0.01 mg/ml leupeptin) and centrifuged at 4,500 × *g* for 15 min at 4 °C. The resulting pellets were resuspended in 250 μl of buffer D, snap-frozen in liquid nitrogen, and stored at −80 °C. All nuclei were isolated under red light conditions to prevent photoactivation of WC-1.

#### Chromatin Immunoprecipitation

The ChIP assays followed the general outline described previously ([@B63], [@B64]) but modified and performed on isolated nuclei to increase efficiency in *Neurospora* ([@B65]). Isolated nuclei were suspended in 5 ml of buffer C (0.015 [m]{.smallcaps} Hepes, pH 7.4, 0.06 [m]{.smallcaps} KCl, 0.015 [m]{.smallcaps} NaCl, 0.01 [m]{.smallcaps} sodium bisulfite, 0.3 [m]{.smallcaps} sucrose, β-mercaptoethanol, 0.5 m[m]{.smallcaps} spermidine, 0.15 m[m]{.smallcaps} spermine), cross-linked in 1% formaldehyde, and then quenched with 0.1 [m]{.smallcaps} glycine for another 15-min incubation. The solution was centrifuged at 13,000 × *g* for 5 min to pellet the nuclei. Pellets were suspended in 5 ml of FA lysis buffer (0.05 [m]{.smallcaps} Hepes, pH 7.4, 0.15 [m]{.smallcaps} NaCl, 0.001 [m]{.smallcaps} EDTA, 1% Triton X-100, 0.1% SDS) containing protease inhibitors (0.002 mg/ml leupeptin, 0.002 mg/ml pepstatin A, 0.001 [m]{.smallcaps} PMSF) and sonicated four times at 50% power and then six times at 65% to an average size of 500 bp. Equal amounts of sheared chromatin was incubated with WC-2 ([@B66]) or H3K4me3 (Millipore) antibody plus protein A-conjugated magnetic beads (Dynabeads) overnight at 4 °C with constant mixing. The beads were washed five times with FA lysis buffer and then eluted twice with elution buffer (0.1 [m]{.smallcaps} sodium bicarbonate, 1.0% SDS) by incubating for 15 min at 42 °C. The cross-links were reversed by adding 2 μl of 5 [m]{.smallcaps} NaCl and incubated for a minimum of 4 h at 65 °C. Protein was removed by the addition of 4 μl of proteinase K (10 mg/ml), 4 μl of 1.0 [m]{.smallcaps} Tris-HCl, pH 6.5, 2 μl of 0.5 [m]{.smallcaps} EDTA, pH 8.0, and incubating at 42 °C for 1 h. DNA was purified using a Qiagen spin column or by a phenol/chloroform extraction. 2 μl of the purified DNA was used in a quantitative PCR with primers specific to the C-box, the PLRE, or the *frq* coding region (FCR)[^3^](#FN3){ref-type="fn"} ([@B40]).

#### DNA Methylation and Southern Blot Analysis

Total *Neurospora* DNA was isolated from a 50-μl volume of ground tissue using the Gentra Puregene DNA isolation kit (Qiagen) following established guidelines ([@B67]). DNA methylation in the *frq* promoter was assayed by methylation-sensitive Southern blots using digoxigenin-labeled DNA probes (Roche Applied Science). Briefly, 10 μg of chromosomal DNA was digested with both BfuCI (methylation-sensitive) and DpnII (methylation-insensitive), then resolved on a 1.0% agarose gel, and transferred to Hybond N+ nitrocellulose membrane (GE Healthcare), and the region of the *frq* promoter was detected with digoxigenin-labeled PLREme probe. Complete digestion was determined by probing for a region of the mitochondrial genome.

RESULTS
=======

In *Neurospora,* CSW-1 and CHD1 remodel chromatin and are required for proper regulation of *frq* ([@B39], [@B40]). However, it is unclear how these enzymes associate with chromatin. In mammals, CHD1 is known to bind to H3K4me3 via the double chromodomain, whereas binding of yeast CHD1 to chromatin is still unresolved ([@B68]--[@B70]). It seems likely that modifications to histones, possibly methylation, might serve as the recognition motif for either or both enzymes. Therefore, we took a systematic approach and began examining lysine methyltransferase deletion strains from the *Neurospora* knock-out collection for clock phenotypes. A strain lacking the KMT2 enzyme, SET1 (FGSC15827), was backcrossed to a strain carrying the *ras-1^bd^* allele, and rhythms in conidia formation were analyzed on race tubes. Comparison of the Δ*set1, ras-1^bd^* strain to an isogenic clock wild type (WT) on race tubes indicated an apparent defect in clock function as indicated by a lack of robust oscillations in banding ([Fig. 1](#F1){ref-type="fig"}*A*). SET1 is part of a large holoenzymatic complex (also known as COMPASS for [comp]{.ul}lex [as]{.ul}sociated with [S]{.ul}ET1) that contains several additional subunits ([@B71]). To examine the requirement of the other SET1/COMPASS subunits in clock function, deletion strains corresponding to SET1/COMPASS subunits were examined in a similar manner. Strains lacking two of the subunits (SWD1 and SWD3) appeared identical to Δ*set1* and are thus also required for clock-dependent SET1 activity. Surprisingly, some subunits (SWD2 and SDC1) appeared to be dispensable for rhythms in conidia formation, with the banding pattern being indistinguishable from WT. Most notably, a strain lacking SWD2, which is the only essential subunit of SET1/COMPASS in *Saccharomyces,* is viable in *Neurospora* and appeared identical to the clock-WT. This may suggest that certain subunits of SET1/COMPASS could function differently at the *Neurospora* clock gene than in lower eukaryotes.

![**SET1 is required for normal circadian rhythms.** *A,* Δ*set1* (XB77-1) and other subunits found in the COMPASS complex were grown on race tubes alongside WT (XB136-6) to determine the circadian phenotype. Data are presented for seven circadian cycles after a light to dark transfer. An apparent arrhythmic conidiation phenotype is observed for Δ*set1*. Additional subunits of the Set1/COMPASS are shown, and the data indicate that *swd2* and *sdc1* are dispensable for circadian-regulated gene expression. *B,* WT (FGSC 2489) and Δ*set1* (XB140-10) were entrained with a standard light to dark transfer and harvested after incubation in the dark (*DD*) for the indicated time. The corresponding circadian time (*CT*) is shown. qRT-PCR data indicate an apparent clock defect in circadian-regulated *frq* expression. A cDNA library was generated using random hexamers to compare Δ*set1* to WT (FGSC 2489) over a 2-day circadian cycle, and levels of *frq* were determined with oligonucleotides specific for the *frq* transcript. *Error bars* represent the mean ± S.D., and the *asterisk* marks a statistically significant difference. *C,* immunoblot analysis of the FRQ protein confirms the clock defect observed in the qRT-PCR data. *LLC,* constant light. *D,* strand-specific qRT-PCR was performed on WT (FGSC 2498) and Δ*set1* (XB140-10) probing for the antisense *frq* transcript, *ASfrq. Sub*, subjective day and subjective night.](zbc0131341830001){#F1}

The apparent arrhythmic phenotype of SET1/COMPASS subunits indicated that H3K4 methylation is required for rhythmic expression of *frq,* or there was phenotypic masking of an underlying rhythm. The defect in clock function was further examined using quantitative RT-PCR looking at the rhythm in *frq* mRNA. The results shown in [Fig. 1](#F1){ref-type="fig"}*B* indicate that Δ*set1* has an altered rhythm in expression compared with WT. In particular, there seems to be a defect in negative feedback inhibition as indicated by the high levels of expression in Δ*set1* relative to the WT at the DD24 time point ([Fig. 1](#F1){ref-type="fig"}*B*, *WT CT* 12--13, marked with an *asterisk*). To further define the defect in *frq* expression, rhythmic levels of the FRQ protein were examined by immunoblot analysis using antibodies specific to FRQ. There appears to a defect in FRQ expression that is consistent with the qRT-PCR results and race tubes ([Fig. 1](#F1){ref-type="fig"}*C*) with newly synthesized FRQ replacing hyperphosphorylated forms that are degraded. This is in comparison with the rhythm observed in WT. These data suggest that H3K4 methylation is required for efficient feedback inhibition of the central clock gene. This result contrasts recent findings in the mammalian clock, where the KMT2, MLL1, is required for activation and rhythmic expression of *mPer2* ([@B55]). Moreover, these data are consistent with the initial characterization of the *set1* mutant in *Saccharomyces* indicating that it was involved in rDNA silencing and silencing of genes near telomeres ([@B72], [@B73]), but it conflicts with the notion that H3K4 methylation is solely a mark for activation.

It is possible that the defect observed in *frq* expression may be due to misregulation of the antisense *frq* transcript (*ASfrq*). To explore the possibility that SET1-dependent methylation was affecting *ASfrq* regulation, we examined *ASfrq* transcript levels by strand-specific qRT-PCR but were unable to detect any notable defects ([Fig. 1](#F1){ref-type="fig"}*D*). However, it is often difficult to measure differences in *ASfrq* because it is expressed at a very low level. Regardless of the mechanism, it is clear that *frq* is misregulated in strains lacking SET1. Moreover, based on the race tube phenotype, other clock-controlled genes are also likely affected, but it is unclear if this is direct or indirect.

To further define the defect in clock function, we used a *frq*-luciferase reporter construct consisting of the *frq* promoter fused to a codon-optimized luciferase ([@B59]). Luminescence was examined over 5 days sampling every hour. We were unable to detect any discernable rhythm in any spores examined ([Fig. 2](#F2){ref-type="fig"}*A*), although we cannot rule out an underlining rhythm that may be masked due to defects in luciferase protein turnover or possible alterations in ATP levels. There also appeared to be a delay in activation relative to WT, indicating SET1 may function as an activating mark when the *frq* promoter is fused to luciferase and integrated at a separate genomic locus (*i.e. frq*-luciferase may behave as a *ccg*).

![**Characterization of expression defects in Δ*set1*.** *A,* clock rhythms were examined using the *frq* promoter fused to codon-optimized firefly luciferase. Strains FGSC 9014 with pVG110 and four independent isolates containing both Δ*set1* and pVG110 (XB157) were grown on luciferin race tubes, and luminescence was monitored for 120 h with sampling each hour. *RLU,* relative light units. *B,* quantitative RT-PCR comparing the steady-state levels of the *al-2* transcript in WT (FGSC 2489) compared with Δ*set1* (XB140-10) at the indicated times. *Sub*, subjective day and subjective night.](zbc0131341830002){#F2}

To determine whether the apparent defect in repression is unique to *frq,* we proceeded to examine expression of the *albino-2* (*al-2*) gene in the *set1* deletion ([Fig. 2](#F2){ref-type="fig"}*B*). We observed a lower level of *al-2* expression in Δ*set1* compared with WT that is consistent with the canonical role of SET1 in gene activation at all time points examined.

### 

#### H3K4 Methylation Occurs at frq

To further define the role of H3K4 methylation in circadian-regulated *frq* expression, we performed a chromatin immunoprecipitation (ChIP) using antibodies that recognize H3K4me3. The ChIP data indicate that H3K4me3 is present at the *frq* locus throughout the entire circadian cycle when compared with the levels observed in Δ*set1* and the IgG negative control ([Fig. 3](#F3){ref-type="fig"}). As expected, H3K4me3 is predominantly present in the *frq*-coding region ([Fig. 3](#F3){ref-type="fig"}*B*), and this is consistent with reports noting that H3K4 methylation is normally localized to coding regions and the transcriptional start site of genes ([@B74], [@B75]). There is also a low level of H3K4me3 in the proximity of the C-box element ([Fig. 3](#F3){ref-type="fig"}*A*). Moreover, there appears to be a low amplitude rhythm in H3K4me3 with peaks occurring during the transcriptional repressive phase (CT9 to CT13). The peak in H3K4me3 corresponds to the repressive phase of *frq* transcription, whereas the trough in methylation corresponds to the activation phase. These data, and the *frq* expression defect observed in Δ*set1,* support the notion that H3K4me3 modulates *frq* and that it is likely a direct effect.

![**H3K4 methylation at *frq* under circadian conditions.** ChIP analysis of H3K4me3 occurring at the *frq* locus. Cross-linked, sonicated lysates enriched for nuclei were isolated from WT (FGSC 2489) under circadian-entrained conditions and immunoprecipitated with an antibody that recognizes H3K4me3. The amount of DNA associated with the modification was determined by quantitative PCR and examined at the C-box (*A*) and within the FCR (*B*). A strain lacking SET1 (XB140-10) and a nonspecific IgG were used as negative controls. Values are the average of four independent ChIP experiments, and the *error bars* indicate the mean ± S.D. (*p* \< 0.05 comparing peak, CT 13--16, and trough, CT 5). *DD*, constant dark; *CT*, circadian time.](zbc0131341830003){#F3}

#### WC-2 Binding Is Altered without SET1

The defects in *frq* expression observed in Δ*set1* led us to reason that binding of WC-2 to the *frq* promoter might also be affected in this strain. Therefore, we examined WC-2 binding to the *frq* C-box promoter element over one and a half circadian cycles by ChIP using polyclonal antibodies specific for WC-2 ([@B66]). Shown in [Fig. 4](#F4){ref-type="fig"} are the average results of four ChIP experiments for each strain. The results demonstrate a defect in WC-2 binding to the C-box element in Δ*set1* relative to WT. We observe a rhythm in WC-2 binding in WT with a peak occurring between CT0 and CT5 (DD12 to DD16) ([Fig. 4](#F4){ref-type="fig"}*A*). In contrast, there was a delay of ∼4 h in the peak of WC-2 binding in Δ*set1* ([Fig. 4](#F4){ref-type="fig"}*B*), which would imply a delay in transcription or a defect in negative feedback inhibition of the *frq* gene consistent with the rhythm in *frq* mRNA.

![**WC-2 binding to the C-box in WT and Δ*set1*.** ChIP analysis of WC-2 binding to the C-box was performed on nuclei isolated from WT (FGSC 2489) (*A*) and Δ*set1* (XB140-10) (*B*). Values are the average of four ChIP experiments normalized to nonspecific background, and *error bars* indicate the mean ± S.D. *DD*, dark; *CT*, circadian time.](zbc0131341830004){#F4}

#### Role of SET1 in Light-activated Gene Expression

H3K4me3 is correlated with transcriptionally active chromatin and is thus thought to facilitate expression even though it was originally implicated in silencing ([@B72], [@B73]). The apparent defect in *frq* repression from the qRT-PCR may result from a defect in down-regulation. In conjunction, the phase delay in the H3K4me3 rhythm at *frq* led us to wonder if SET1 is involved in activation or in modulating down-regulation of *frq*. To accomplish this, we examined the role of SET1 in the *Neurospora* light response to see if there was any difference in expression under these conditions. We performed qRT-PCR in Δ*set1* compared with WT, examining *frq*, *wc-1*, and *vvd* ([Fig. 5](#F5){ref-type="fig"}, *A--C*). Interestingly, the general trend was that Δ*set1* appeared to have a slightly elevated level of light-induced *frq* and *wc-1* but not *vvd* at a subset of time points tested, although not all time points had a 95% confidence level. The lack of high confidence differences presumably stemmed from minor variability in the cDNA library construction, efficiency between experiments, and in the case with light-activated genes, it may be difficult to observe increases greater than maximum expression. Support for this comes from photoadaptation experiments where *Neurospora* is unresponsive to a higher intensity light pulse during the adaptation phase. Regardless of the cause, it is clear that there are consistently higher levels of *frq* and *wc-1* in response to light.

![**Δ*set1* has slightly higher *frq* and *wc-1* expression under light-inducing conditions.** Light-induced gene expression was examined in Δ*set1* (XB140-10) compared with WT (FGSC 2489), and relative levels of *frq* (*A*), *wc-1* (*B*), and *vvd* (*C*) were determined by qRT-PCR. *D,* FRQ protein levels were also examined and appeared to be higher at later time points in Δ*set1* relative to WT. *E,* quantification of FRQ protein levels in response to light. Values are the normalized average of four independent experiments. *F,* level of WC-1 is generally lower in Δ*set1* compared with WT. All *error bars* represent the S.E.](zbc0131341830005){#F5}

To further define *frq* expression in Δ*set1*, we investigated FRQ protein levels in response to light. Immunoblot analysis of FRQ indicates that FRQ expression is elevated in Δ*set1 versus* WT ([Fig. 5](#F5){ref-type="fig"}, *D* and *E*). In contrast, WC-1 protein levels in Δ*set1* ([Fig. 5](#F5){ref-type="fig"}*F*) did not vary substantially comparing WT and Δ*set1*, even though there are minor increases in *wc-1* transcript at some time points ([Fig. 5](#F5){ref-type="fig"}*B*). This may be due to turnover of WC-1 protein by the proteasome. This is a common mode of regulation found in numerous transcription factors ([@B76]), including both CLOCK an BMAL1 ([@B77]), and WC-1 has been shown to be degraded in response to light ([@B78]).

#### H3K4me3 in Response to Light

The observation that Δ*set1* has an increase in the expression of light-responsive genes, combined with phase-delayed peaks in H3K4me3 under circadian conditions, led us to examine the kinetics of H3K4 methylation in response to light. We performed ChIP on cross-linked and sonicated lysates from enriched nuclei using H3K4me3 antibodies probing regions within the *frq* locus. There appear to be no significant change in H3K4me3 after exposure to light for 15 min at the C-box, the PLRE, and within the FCR ([Fig. 6](#F6){ref-type="fig"}), even though this corresponds to the peak in *frq* expression ([Fig. 5](#F5){ref-type="fig"}*A*). However, at 30 min, a time corresponding to the start of VIVID (VVD)-dependent light repression, the levels of H3K4me3 rose and remained elevated with only a slow and steady decrease over the course of the next 2 h. After 4 h in the light, the amount of H3K4me3 returned to the levels observed in the dark (data not shown). The kinetics of H3K4 methylation is consistent with the notion that SET1 plays a role in modulating the amplitude of the light response. However, we cannot rule out the possibility that the low levels of H3K4 methylation seen after 15 min of light are the result of a reduction of nucleosome occupancy within the *frq* locus.

![**H3K4me3 under light-induced conditions.** H3K4me3 within the *frq* locus was examined by ChIP after light induction at the C-box (*A*), PLRE (*B*), and within FCR (*C*). The amount of DNA associated with H3K4me3 was determined by quantitative PCR at the indicated times in the light. Sheared chromatin from Δ*set1* and a nonspecific IgG were used as controls. Average values are from four independent experiments. The *errors bars* represent the S.E.](zbc0131341830006){#F6}

#### DNA Methylation at frq Requires SET1

To further define the role of SET1 in regulating the chromatin state at *frq,* we examined the levels of DNA methylation in the *frq* promoter. The impetus for this experiment arose from the observation that there is typically a strict anti-correlation between H3K4 methylation and DNA methylation. Normally when H3K4 methylation is high, there is an absence of DNA methylation, and when DNA methylation is high, genes are typically devoid of H3K4 methylation. In fact, it has been shown that the mammalian SET1/COMPASS contains a C*XX*C protein, Cfp1, which is targeted to unmethylated CpG islands ([@B79]). The observation that H3K4me3 is present at all times examined in the ChIP experiments, combined with the observation that DNA sequences within the *frq* promoter are methylated under circadian entrainment conditions, led us to examine this relationship. We proceeded to examine if there were defects in normal DNA methylation at *frq* in Δ*set1* by performing a methyl-sensitive Southern blot. We compared total genomic DNA digested with the methylation-sensitive restriction endonuclease *Bfu*CI and its methylation-insensitive isoschizomer, *Dpn*II, followed by Southern blot analysis using a probe specific to the *frq* promoter ([@B80]). We probed DNA isolated from two specific time points (DD12 and DD24, which correspond to WT CT0 and CT12, respectively) from WT and Δ*set1* using the clock-defective *frq*^9^ (hypomethylated) and Δ*dim-2* (no methylation) as controls ([Fig. 7](#F7){ref-type="fig"}*A*). To ensure that the lack of *Bfu*CI digestion was due to DNA methylation, we stripped and probed the blots again and then examined a region in the mitochondrial genome ([Fig. 7](#F7){ref-type="fig"}*B*). Mitochondrial DNA, which is never methylated, but is at much higher concentrations relative to nuclear DNA, was completely digested confirming that the partially digested DNA at *frq* was due to DNA methylation.

![**DNA methylation at *frq* requires SET1.** *A,* methylation-sensitive Southern blot was performed on WT compared with Δ*set1* from DNA isolated from 12- and 24-h time points. DNA was digested with BfuCI (*B*) and DpnII (*D*) and resolved on a 1% agarose gel, and DNA methylation was determined by probing a region of the *frq* promoter that is methylated. A strain with the *frq*^9^ allele (hypomethylated) and a strain lacking the DNA methyltransferase *dim-2* were added as controls. All the samples shown are contained on the same blot but separated to remove unrelated information. *B,* blot was stripped and probed a second time for a region within the mitochondrial genome. *MitoP*, mitochondrial probe. *C*, expression of the dim-2 transcript was analyzed by qRT-PCR in WT compared with Δ*set1*.](zbc0131341830007){#F7}

The complete dependence of DNA methylation on H3K4 methylation observed in Δ*set1* was indistinguishable from the Δ*dim-2* mutant. This is a significant observation because of the anti-correlation between DNA methylation and H3K4 methylation stated above. A possible explanation for this observation may be the lack of expression of *dim-2* in Δ*set1*. However, this was ruled out because *dim-2* expression is largely unaffected in strains lacking SET1 ([Fig. 7](#F7){ref-type="fig"}*C*). The molecular mechanism behind DNA methylation at *frq* is still unresolved, but it is clear in this case that DNA methylation is dependent on H3K4 methylation. However, we cannot rule out the possibility that expression of other genes needed for DNA methylation are low (or not expressed) in the absence of SET1.

DISCUSSION
==========

Both CSW-1 and CHD1 remodel chromatin at *frq* and are needed for the maintenance of circadian rhythms in *Neurospora* and either may associate with chromatin via histone methylation. With that in mind, we set out to determine whether methyl modifications to chromatin are involved in circadian rhythms and whether they share similar phenotypes to either Δ*csw-1* or Δ*chd1*. We began by examining a subset of histone methyltransferases and identified SET1/COMPASS. Strains lacking *set1* or a subset of other SET1/COMPASS subunits have an apparent arrhythmic clock phenotype on race tubes. Further analysis of molecular rhythms either by qRT-PCR, Western blot, or using a *frq*-luciferase reporter construct confirms the defect in *frq* expression in Δ*set1*. There is also a delay in H3K4me3 following the peak in *frq* expression under both circadian- and light-induced gene expression suggesting that H3K4me3 may play a role in the down-regulation of *frq*. We cannot rule out the possibility that activation is delayed under circadian conditions due to the loss of *set1* or the excess abundance of light-expressed FRQ, which would lengthen the period and give it an apparent defect in inhibition. Moreover, it is possible that splicing of the *frq* transcript is delayed or less efficient in the absence of *set1*, and this would be consistent with reports showing that H3K4 methylation serves as modification linking CHD1 with components of the spliceosome ([@B69]). This is unlikely to be the case here because *Neurospora* CHD1 is more similar to yeast CHD1 and likely does not associate with H3K4me3 ([@B68]), and the phenotypic differences between Δ*chd1* and Δ*set1* indicate they are unlikely to be in a parallel pathway. Also, it is not entirely consistent with light activation experiments, where we routinely observed higher levels of *frq,* suggesting that SET1 may serve to repress expression at this locus. This is certainly unexpected because of the strong correlation between H3K4me3 and transcriptional activation and raises the following question. How prevalent is this throughout the genome? When we examined expression of *al-2*, we found that it behaved as one might predict for an activating modification, and the *al-2* transcript was much lower than in WT. Microarray studies in *Saccharomyces* indicates that genes close to telomeres have an increase in expression in Δ*set1,* but this is likely due to its role as an antisilencing factor and would be limited to telomeric regions and/or heterochromatic regions ([@B81]). Might *frq* be regulated in a similar fashion to genes near telomeres? Only time will tell, but many of the chromatin-modifying enzymes implicated in clock function also function at telomeric regions, most notably SIRT2 ([@B51], [@B52]). In addition, the seemingly contradictory observation that SET1 plays a role in silencing at *frq* fits nicely with the notion that the clock is regulated by facultative heterochromatin and may indicate a spreading of facultative heterochromatin to an adjacent loci in Δ*set1* leading to elevated levels of expression.

Consistent with the observed phenotypes and defects in molecular rhythms, we also find defects in rhythmic binding of the transcription factor WC-2. WC-2 normally has a robust rhythm in binding to the C-box sequence. In the absence of SET1, binding is different from what is typically observed in WT. Combined with the detectable rhythms in H3K4me3 observed at *frq,* it seems likely that SET1 functions as a direct regulator of *frq* expression. Assuming for a moment that the clock is regulated by facultative heterochromatin, loss of *set1* may cause a spreading in heterochromatin that leads to defects in silencing (as is the case with telomeric regions), and this would then generate more accessible chromatin that would allow WC-2 to bind longer and lead to longer periods with elevated expression.

The notion that SET1 is involved in modulating inhibition of *frq* in *Neurospora* is based on the compilation of the data. First, we always see elevated levels of *frq* transcript and FRQ protein in response to light in Δ*set1*. Second, we observed elevated levels of *frq* mRNA expression at the DD24 time point (WT CT12), a time when *frq* is normally inhibited. Third, Δ*set1* is phenotypically and molecularly identical to Δ*csw-1,* and this strain also has an apparent defect in negative feedback inhibition ([@B40]). Whether CSW-1 binds to the H3K4 methyl modification will certainly need to be tested in later studies. These data on Δ*set1* appear to contrast an elegant report on the role of MLL1 in the mammalian circadian system ([@B55]). However, the observation that WDR5 is associated with both PER1 and PER2 indicates that the process in the mammalian system is more complicated than current literature indicates ([@B82]).

One of the more intriguing aspects of this report is the idea that DNA methylation is dependent on H3K4 methylation, albeit possibly indirectly. How DNA methylation at *frq* is established is still unknown, but it seems likely that it is a complex cascade of oscillating chromatin modifications and may involve alternating transcription of the sense and antisense transcripts producing Dicer-independent small interfering RNAs that direct the DNA methylation ([@B56]). SET1 is just one component in this process, and if H3K4 is missing, subsequent modifications that are direct may, by default, be absent. In other words, loss of H3H4me2/3 may cause a defect in a subsequent modification (*i.e.* H3K9me3) that is needed for DNA methylation. The exact molecular mechanisms leading to DNA methylation at *frq* will certainly take time to determine, but no longer is there a hard and fast rule that if H3K4 methylation is absent, then DNA is likely methylated. Regardless of the details that will certainly be worked out in the future, it is clear that in all eukaryotic clocks studied to date, clock regulation of chromatin structure is a vital component of both the activation phase and repressive phase of the transcriptional negative feedback cycle.
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